INS and metabolic dysfunction-associated steatotic liver disease: With increasing incidence rates of neurodegenerative diseases like AD and insulin resistance disease states such as type 2 diabetes, obesity, non-alcoholic fatty liver disease, and metabolic syndrome, this study underscores the importance of preserving insulin sensitivity and the integrity of the insulin signaling pathway [46].